Small Pharma Inc.
DMTTF · OTC
2/28/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18,537 | $40,656 | $5,778 | $563 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $800 | $800 | $476 | $222 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $20,324 | $43,012 | $6,515 | $784 |
| Property Plant & Equip (Net) | $660 | $62 | $72 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $2,500 | $0 | $0 |
| Total NC Assets | $660 | $2,562 | $72 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $20,984 | $45,574 | $6,587 | $788 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $304 | $304 | $8,827 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,218 | $3,218 | -$4,330 | $0 |
| Total Curr. Liab. | $3,521 | $4,497 | $12,357 | $78 |
| LT Debt | $306 | $306 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | -$306 | $0 | $0 |
| Total NC Liab. | $306 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,827 | $4,497 | $12,357 | $78 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $69,723 | $69,970 | $3,244 | $3,146 |
| Retained Earnings | -$54,641 | -$31,709 | -$9,443 | -$2,408 |
| AOCI | -$2,043 | -$194 | -$181 | -$29 |
| Other Equity | $4,117 | $3,009 | $47,456 | $0 |
| Total Equity | $17,156 | $41,077 | -$5,770 | $709 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $20,984 | $45,574 | $6,587 | $788 |
| Net Debt | -$17,927 | -$40,047 | $3,049 | -$563 |